Exome Asset Management LLC
•CIK: 2011932•Filing: Q4 2025
**Exome Asset Management LLC** manages $209M across a portfolio of 60 positions, exhibiting a concentrated, sector-specific investment mandate. The fund's top holdings reveal significant allocations to biotechnology and healthcare, notably PRAX ($17.1M) and COGT ($10.9M). Further concentration is evident with positions in GH ($10.0M) and ISI ($9.2M), suggesting deep conviction in specific growth catalysts within the life sciences sector. This structure points to a high-conviction, research-intensive approach targeting outsized returns from specialized market segments.
Total AUM
$202.4M
+ $6.7M in options
QoQ Performance
+33.7%
Positions
53
+ 7 options
Top 10 Concentration
42.7%
Latest Filing
Q4 2025
Top Holdings Allocation
PRAX
COGT
PRAX8.2%
COGT5.2%
GH4.8%
ISI4.4%
LLY4.0%
CYTK3.8%
WVE3.4%
VERA3.0%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other95.0%
Healthcare5.0%
🚪 Exited Positionssold since Q3 2025
+29 more exited positions
Changes from Q3 2025
NEW26 new positions
↑5 increased
↓16 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023